- Home
- Bioenergetic Devices
- Bioresonance
- BIOLOGICAL RESONANCE AND THE STATE OF THE ORGANISM - FUNCTIONAL ELECTRODYNAMICAL TESTING
BIOLOGICAL RESONANCE AND THE STATE OF THE ORGANISM - FUNCTIONAL ELECTRODYNAMICAL TESTING
- By Gabor Lednyiczky
- Published 07/30/2008
- Bioresonance
-
Rating:
WHERE IS THE BORDERLINE BETWEEN THE POSSIBILITY OF RECOVERING BY NATURAL SELF-REGULATIVE MECHANISMS?
The Biodiagnosis and Biofeedback functions of the CMMI provide a fresh perspective on the “health” of a patient. As physicians well know, as many parameters as possible of a patients state should be taken into consideration when making a diagnosis. However, even the most extensive questioning of a patient, may not yield proper results as the patient may fail to answer questions correctly, forget certain details, over- or underestimate their condition, or, conceivably, deliberately attempt to deceive the physician. The most common analogy of determining the health of a patient based on the external factors alone, is that of trying to determined the structure of an iceberg based on an examination of the above-water structure. The physician is often forced to use invasive techniques, which, by definition of their being invasive, they necessarily alter the patient’s condition, further complicating the diagnosis (as well as often introducing unexpected side-effects). Low intensity electromagnetic signals are used in the CMMI in order to avoid a possible invasive character of the diagnosis. Low intensity signals make it possible to identify endogenous regulatory processes rather than to list all kinds of functional and morphological disorders. The latter is definitely not sufficient to estimate the extent of treatment intervention that will be adequate to the body state. To be successfull, the treatment should resonate with the pace of the changes - either positive (curative) or negative - in the body state. The pace of such changes, in turn, depend on the vital reserves of the organism. These vital reserves are tested by using the “adaptation test” option of the CMMI with respect to different stressors information about which is available as extremely low electromagnetic signals of the corresponding substances implanted in the device.
FEDT = FUNCTIONAL ELECTRODYNAMIC TESTING WITH THE CMMI
With the CMMI, a physician can determine the electromagnetic state of a patient, and from this can make a diagnosis without the necessity of invasive methods.
During the Biodiagnosis procedure, the patient is briefly (40ms, though adjustable) exposed to the magnetic fields of over 2000 homeopathic substances (not simultaneously, of course). Then, the patient’s reaction to that substance is measured as value of the voltage changes (e.g., between the two wrist electrodes) and is translated into the reactivity (an average of the voltage fluctuations). Once all substances have been tested, the program establishes an overview of the patients integrity through the “Statistics” function.
As is mentioned above, every organism is in a constant feedback system with its environment. The statistics function measures to what degree a patient is capable of adapting (participating) to the environment. There may be a variety of reasons (both physiological and psychological) for this over- or under-adaptation, which naturally, the physician will have to determine. The uniqueness of this feature is that what a physician previously had to estimate (based on experience and intuition), can now be quantified, and even shown to the patient.
Each time the patient is tested, the substance list and statistics will be different. This may be alarming at first, as one of the most seemingly basic functions of a diagnostic device should be to deliver the same diagnosis given the same conditions. And here lies the key: the organism never experiences the same conditions from one moment to the next, so necessarily, the device will not provide exactly the same diagnosis from one minute to the next. In our age of massive toxic, nuclear, and electromagnetic pollution, as well as rapid transportation, an individual’s fluctuations are more and more dynamic, they change every moment.
The device is a dynamic measurement system, and, as such, its power is in its ability to determine these very changes that happen from one moment to the next. Specifically, the physician, once having established the overall adaptability of a patient, can then go the repeat test function.
If the patient has either too narrow or too wide a statistics function the physician might consider terminating the test at that point and recommending to the patient possible ways of normalizing the overall reaction. In any case, the general adaptability of the patient must be considered for all repeat tests as all measured values are relative to the initial measurements.
The physician’s initial assessment of the patient, combined with the statistics results, and the list of items on the “Substance List” can be used to then isolate the substances which are the most crucial to the contribution of the patient’s condition. The adjusted values of +120 to -120 can be considered as informational values in that a strong reaction (far from 0) indicates the organism’s missing or needed information which it is no longer getting from the environment. And here again, the dynamics of the reaction are crucial to a proper diagnosis.
Due to the fact that the patient is exposed to the informational character of the substances, the diagnostic procedure is a kind of treatment itself. This means that these initial reactions serve primarily as markers. It may be that the patient only needed the very brief exposure to the information, and reacted strongly initially, but the physician should not immediately assume that values which initially appeared with high values are what the patient’s body needs.
Through repeated applications of the “Adaptation Test” (Transmit Button), the physician can determine to what extent the information is needed, or over saturated with. A patient’s adaptability to a particular substance is indicated by the subsequent “Reactivity”, “Rise”, and “Fall” values as well as the character of the line. The adaptability to the information of a certain substance reveals how much that information is needed, as well as indicating possible pathologies from the inability to adapt to that substance.
In this way, the physician can simulate a homeopathic treatment and subsequently determine the expected and possible therapeutic effects regarding the tested substance.
DIAGNOSTIC PROCEDURE FOR THE CEREBELLUM MULTIFUNCTION MEDICAL INSTRUMENT
1. Anamnesis
First of all, it’s very important to get enough information from the patient in order to conceive the primary hypothesis. All kinds of data can provide important information concerning symptoms and their development (pathogenesis). In the holistic approach, all things and processes are considered to be interlinked. Despite the body’s ability to express (by the measured electrical parameters) its reactions with a finite speed, time sets certain limitations to our measurements (that is, patients ususally don’t have an entire day for a diagnosis). The preliminary hypothesis creates a kind of base line from which the outcome of the electrical diagnosis can be compared. This can provide a justification by the measured results or an adjustment where you can include pathogenic components or skip some of the ones you included in your preliminary hypothesis.
2. Automatic Measurement
It is practical to start with a general screening, chose “all substances”. There are always substances (aspects) which may be forgotten while conceiving the primary hypothesis, here you will have a chance to identify them on the screen. A reaffirmation of the primary hypothesis is the other goal of this step of the diagnostics process. The differences between your primary hypothesis and automatic measurement results remain for further testing. The permanent comparison of the results of the “Automatic Measurement” with the information from the anamnesis shall lead you on through further testing.
3. Statistics
The shape of the distribution diagram (number of substances plotted against the measured value of the electrophysical parameter under consideration) represents the ability of the organism to react (participate) to its environment, e.g. to the changes in it. This correlates to organism’s reactions to the tested substances. On the x-axis, values from 0 to 4096 correspond to an adjustable voltage measurement of +3mV (4096) to -3mV (0), therefore, 2048 signifies no measurable reaction (0 Volts). The number of substances is plotted on the y-axis. Usually, the distribution of the measured values is non-Gaussian In all distribution diagrams, the Gaussian distribution is shown as a reference only, and does not correspond to the patient’s actual distribution diagram. If the wings of the distribution of the plot are broad, it means that the organism reacted very intensely to many substances (fig. 2). An extremely high peak at the middle corresponds to low reactivity (i.e., with the measurement parameters applied (fig. 3)), and means that a fast, general test (short exposure time) cannot be performed the on the patient. The distance between the maximum and minimum values (on the x-axis) measured from a particular patient is linearly subdivided into 240 units regardless of the number of measured substances. The newly obtained scale is labeled starting from -120 (at the minimum initial value) up to +120 (maximum initial value). From this, the patient’s individual distribution list is generated to serve as the base line for “Repeat test” measurements. We are interested in the amplitude of the changes due to adaptation which should be considered within the individual range of fluctuation of the electrophysiological parameters.
Fig. 1. An example of a commonly found distribution diagram of a patient’s reaction.
Fig. 2. Distribution diagram of a hypererg patient’s reaction during the automatic test
Broad wings signify a decreased integrity of the organism and an over-reactiveness to environmental changes without effective compensation. This distribution is mostly found in multiple-allergic patients and by those who are exposed to extreme environmental pollution.
Fig. 3. Distribution diagram with extremely diminished wings
A lack of wings indicates that the body doesn’t want to show individual reactions/participate and that it is keeping its integrity with all of its forces. This is a sign of an over-compensated state (called masking in allergy studies), when neural and informational systems are no longer responding because the organism does not want to risk its stability (integrity). This is found mostly in patients with a severe chronic overload coupled with strong determination, like many high position bank managers, and noticeable emotional control (stoic patients), and also in some introverted, psychologically unstable patients. Patients with this type of distribution need certain preparatory treatments before becoming electrically responsive. This is possible with the treatment unit, or by applying longer “transmit” triggers of this diagnostic unit.
4. Result list
When the SUBSTANCE LIST window (located at the lower left corner of the screen, Fig. 4) appears after the calculations are finished, it begins by listing ALL SUBSTANCES. The x-coordinate of any substance (in the 240-point scale defined above) is listed starting with 120 (extreme right position in the distribution diagram) down to - 120 (extreme left position). If you want to examine the results within a specific category of substances, you can click on a group name and open that group. The substances which compose the group will appear (in “Normal Sort” mode) listed by their x-coordinate in descending order. One should keep in mind that all values are measured on a relative scale, all values are relative to the patient in the moment that the measurements were taken. This serves the purpose of obtaining the dynamics of the patient’s reactions to the tested substances during the REPEAT TEST period. However, a good starting point is to assume that values above 60 or below -60 indicate a “high reaction”. Always relate those values to the shape of the “Distribution Diagram”. Now we can compare the differences between the preliminary hypothesis and those values measured by the functional electro-diagnostic testing (FEDT) in the automatic mode.
There will always be only a partial overlap between the lists of the substances with expected high values and actually measured high absolute values. Those which confirm the preliminary diagnostic hypothesis need not be “Repeat tested”. Yet, if you want to estimate the pathogenic priority of these substances and test the organism’s specific regulative capacity toward each of them, the ADAPTATION TEST can be carried out. For substances which were expected but do not appear with high absolute numbers, the “Repeat Test” will help to decide whether we had a false assumption in the preliminary diagnostic hypothesis or may indicate that the organism needs more time to express itself specific to the investigated substance. This group of substances should be included in the REPEAT TEST phase of the diagnostic process. Some substances which were not explicitly expected, but came up with high absolute values correlate well to the pathogenesis and the epicrisis and will not necessitate further testing. For further investigations, this can be considered as similar to the substances belonging to Case “A”. Still more substances which were not explicitly expected but came up with a high absolute value will correlate either questionably or poorly. These substances need to be investigated more thoroughly should be added to the REPEAT TEST phase. It can happen that the user may not be familiar with some of the substances listed on the screen. In this case, the best thing to do for the moment is to ignore them. So as not to create confusion, make your search for the unknown substance after the well known substances have found their place in your diagnostic picture.
Fig. 4. End test result window.
5. Adaptation Test
The ADAPTATION TEST function consists of first, a period of contact for several seconds (adjustable from the software, usually 5 seconds) between the substance and the patient, then the usual testing of the patient’s reactions. This allows the “Adaptation Test Diagram” to provide an exact insight into the dynamics of the reaction. By repeating the ADAPTATION TEST, we can get the most detailed diagnostic information. “Reactivity” indicates the average of the 16 channels’ results during the entire period which was monitored. “Rise” indicates the highest deviation upwards from the average. “Fall” indicates the largest deviation downwards from the average. In the “Adaptation Test Diagram” on the vertical axis, we can see the amplitude of the signal measured in the same units as the x-axis of the STATISTICS TEST. On the horizontal axis, time is indicated in milliseconds. The actual measured values are depicted in red, “Reactivity” is represented by the flat green line corresponding to the overall average during the actual measurement period. (In later models, the vertical amplitude axis is represents only the actual interval according to the actually measured intensities during the “Test Measure Time” .) Normally, we expect “Reactivity” to settle down around 2048, “Rise” and “Fall” should be lower than 40 (in later models, 204.8, and 4.0 respectively). In order to understand the dynamics of the ADAPTATION TEST, the following tendencies are listed:
First of all, we follow the changes in the “Rise” and “Fall” parameters. The dynamics of the patient’s adaptation to the field of a therapeutically diluted substance is very significantly characterized by the fluctuations of its electric parameters in both frequency and amplitude. The maximum amplitude of fluctuation is characterized by the “Rise” and “Fall” values.
Usually, we include in the ADAPTATION TEST only substances which seem to play a key role in the epicrisis presented by the patient and here we want to collect information about which aspect of the pathology should be first treated. We are looking for not only the primary causes but also the principle stressors, the elimination of which brings about the opportunity for normal self-regulation of the organism. The ADAPTATION TEST makes it possible (through the reaction to the test substances) to identify the conditions under which the body’s self-regulation activities seem to be insufficient and substitution therapy or other more invasive treatments may be required.
In the case of a fast normalization of the “Rise”, “Fall”, and “Reactivity” values (e.g. within two ADAPTATION TESTS), we can conclude that a cell communication enhancement treatment (such as bioresonance therapy) would give the necessary first push and the organism could accomplish the rest of the recovery.
If the “Rise” and “Fall” values are only partially normalized (e.g., a stepwise function coming down from a higher value to a significantly lower value) we should consider a temporal administration of home medication in addition to cell communication adjustment treatments.
If “Rise” and “Fall” values don’t tend to normalize even after 3-4 ADAPTATION TESTS, then the organism is incapable of any detectable degree of self-correction concerning the tested substances. In this case, the revealed principle pathogen agent cannot be treated by a local enhancement of the damaged endogenous control mechanisms. Thus, the identified substance is a significant contributor to the patient’s pathology, and a longer preparation phase in the treatment is required before causal therapy can be applied (since at the moment, the organism has no vital reserves to react to a specific treatment regarding this substance).
In some few cases, we find a strange kind of extreme fluctuation of the “Rise” and “Fall” values (from several hundred to almost zero and back repeated several times). This indicates a very severe situation, potentially due to a lack of vital reserves. The body is trying to decide whether to ignore this substance or adapt to its field, and confusion ensues. This situation must be treated very carefully, and it requires that the body’s vital reserves are built up first because if the body is treated with this substance, the patient will develop a fever. Therefore, ignore this substance in the treatment until the patient’s vital reserves will be sufficient.
Fig 5. Adaptation Test result window.
Figure 6
As Fig.7 shows, all measurement characteristics can be adjusted from the software. We usually connect the patient and the test-substance for 40 ms and start measurement with the smallest possible delay time of 1 ms. One measurement block consists of 110 ms. With the usual measurement time of 80 ms this provides a 70 ms relaxation time for the body after connection with each subsequent test substance. Since immediate adaptational activity is the object of interest, these parameters are convenient in clinical practice. However, in the case of an extreme mesenchimal block (a solid disturbance in the mesenchimal matrix which makes endogenous information transfer, i.e., electric connection, very poor), the measurement and relaxation times should be elongated.
For carrying out the adaptation test, a longer period of connection between the test-substance and the patient (the Transmit time) is applied, usually 5-7 seconds. Changes in the dynamics of the reactivity are monitored (see references 60 and 61 for a more detailed description).
Figure 7:
The Biodiagnosis and Biofeedback functions of the CMMI provide a fresh perspective on the “health” of a patient. As physicians well know, as many parameters as possible of a patients state should be taken into consideration when making a diagnosis. However, even the most extensive questioning of a patient, may not yield proper results as the patient may fail to answer questions correctly, forget certain details, over- or underestimate their condition, or, conceivably, deliberately attempt to deceive the physician. The most common analogy of determining the health of a patient based on the external factors alone, is that of trying to determined the structure of an iceberg based on an examination of the above-water structure. The physician is often forced to use invasive techniques, which, by definition of their being invasive, they necessarily alter the patient’s condition, further complicating the diagnosis (as well as often introducing unexpected side-effects). Low intensity electromagnetic signals are used in the CMMI in order to avoid a possible invasive character of the diagnosis. Low intensity signals make it possible to identify endogenous regulatory processes rather than to list all kinds of functional and morphological disorders. The latter is definitely not sufficient to estimate the extent of treatment intervention that will be adequate to the body state. To be successfull, the treatment should resonate with the pace of the changes - either positive (curative) or negative - in the body state. The pace of such changes, in turn, depend on the vital reserves of the organism. These vital reserves are tested by using the “adaptation test” option of the CMMI with respect to different stressors information about which is available as extremely low electromagnetic signals of the corresponding substances implanted in the device.
FEDT = FUNCTIONAL ELECTRODYNAMIC TESTING WITH THE CMMI
With the CMMI, a physician can determine the electromagnetic state of a patient, and from this can make a diagnosis without the necessity of invasive methods.
During the Biodiagnosis procedure, the patient is briefly (40ms, though adjustable) exposed to the magnetic fields of over 2000 homeopathic substances (not simultaneously, of course). Then, the patient’s reaction to that substance is measured as value of the voltage changes (e.g., between the two wrist electrodes) and is translated into the reactivity (an average of the voltage fluctuations). Once all substances have been tested, the program establishes an overview of the patients integrity through the “Statistics” function.
As is mentioned above, every organism is in a constant feedback system with its environment. The statistics function measures to what degree a patient is capable of adapting (participating) to the environment. There may be a variety of reasons (both physiological and psychological) for this over- or under-adaptation, which naturally, the physician will have to determine. The uniqueness of this feature is that what a physician previously had to estimate (based on experience and intuition), can now be quantified, and even shown to the patient.
Each time the patient is tested, the substance list and statistics will be different. This may be alarming at first, as one of the most seemingly basic functions of a diagnostic device should be to deliver the same diagnosis given the same conditions. And here lies the key: the organism never experiences the same conditions from one moment to the next, so necessarily, the device will not provide exactly the same diagnosis from one minute to the next. In our age of massive toxic, nuclear, and electromagnetic pollution, as well as rapid transportation, an individual’s fluctuations are more and more dynamic, they change every moment.
The device is a dynamic measurement system, and, as such, its power is in its ability to determine these very changes that happen from one moment to the next. Specifically, the physician, once having established the overall adaptability of a patient, can then go the repeat test function.
If the patient has either too narrow or too wide a statistics function the physician might consider terminating the test at that point and recommending to the patient possible ways of normalizing the overall reaction. In any case, the general adaptability of the patient must be considered for all repeat tests as all measured values are relative to the initial measurements.
The physician’s initial assessment of the patient, combined with the statistics results, and the list of items on the “Substance List” can be used to then isolate the substances which are the most crucial to the contribution of the patient’s condition. The adjusted values of +120 to -120 can be considered as informational values in that a strong reaction (far from 0) indicates the organism’s missing or needed information which it is no longer getting from the environment. And here again, the dynamics of the reaction are crucial to a proper diagnosis.
Due to the fact that the patient is exposed to the informational character of the substances, the diagnostic procedure is a kind of treatment itself. This means that these initial reactions serve primarily as markers. It may be that the patient only needed the very brief exposure to the information, and reacted strongly initially, but the physician should not immediately assume that values which initially appeared with high values are what the patient’s body needs.
Through repeated applications of the “Adaptation Test” (Transmit Button), the physician can determine to what extent the information is needed, or over saturated with. A patient’s adaptability to a particular substance is indicated by the subsequent “Reactivity”, “Rise”, and “Fall” values as well as the character of the line. The adaptability to the information of a certain substance reveals how much that information is needed, as well as indicating possible pathologies from the inability to adapt to that substance.
In this way, the physician can simulate a homeopathic treatment and subsequently determine the expected and possible therapeutic effects regarding the tested substance.
DIAGNOSTIC PROCEDURE FOR THE CEREBELLUM MULTIFUNCTION MEDICAL INSTRUMENT
1. Anamnesis
First of all, it’s very important to get enough information from the patient in order to conceive the primary hypothesis. All kinds of data can provide important information concerning symptoms and their development (pathogenesis). In the holistic approach, all things and processes are considered to be interlinked. Despite the body’s ability to express (by the measured electrical parameters) its reactions with a finite speed, time sets certain limitations to our measurements (that is, patients ususally don’t have an entire day for a diagnosis). The preliminary hypothesis creates a kind of base line from which the outcome of the electrical diagnosis can be compared. This can provide a justification by the measured results or an adjustment where you can include pathogenic components or skip some of the ones you included in your preliminary hypothesis.
2. Automatic Measurement
It is practical to start with a general screening, chose “all substances”. There are always substances (aspects) which may be forgotten while conceiving the primary hypothesis, here you will have a chance to identify them on the screen. A reaffirmation of the primary hypothesis is the other goal of this step of the diagnostics process. The differences between your primary hypothesis and automatic measurement results remain for further testing. The permanent comparison of the results of the “Automatic Measurement” with the information from the anamnesis shall lead you on through further testing.
3. Statistics
The shape of the distribution diagram (number of substances plotted against the measured value of the electrophysical parameter under consideration) represents the ability of the organism to react (participate) to its environment, e.g. to the changes in it. This correlates to organism’s reactions to the tested substances. On the x-axis, values from 0 to 4096 correspond to an adjustable voltage measurement of +3mV (4096) to -3mV (0), therefore, 2048 signifies no measurable reaction (0 Volts). The number of substances is plotted on the y-axis. Usually, the distribution of the measured values is non-Gaussian In all distribution diagrams, the Gaussian distribution is shown as a reference only, and does not correspond to the patient’s actual distribution diagram. If the wings of the distribution of the plot are broad, it means that the organism reacted very intensely to many substances (fig. 2). An extremely high peak at the middle corresponds to low reactivity (i.e., with the measurement parameters applied (fig. 3)), and means that a fast, general test (short exposure time) cannot be performed the on the patient. The distance between the maximum and minimum values (on the x-axis) measured from a particular patient is linearly subdivided into 240 units regardless of the number of measured substances. The newly obtained scale is labeled starting from -120 (at the minimum initial value) up to +120 (maximum initial value). From this, the patient’s individual distribution list is generated to serve as the base line for “Repeat test” measurements. We are interested in the amplitude of the changes due to adaptation which should be considered within the individual range of fluctuation of the electrophysiological parameters.
Fig. 1. An example of a commonly found distribution diagram of a patient’s reaction.
Fig. 2. Distribution diagram of a hypererg patient’s reaction during the automatic test
Broad wings signify a decreased integrity of the organism and an over-reactiveness to environmental changes without effective compensation. This distribution is mostly found in multiple-allergic patients and by those who are exposed to extreme environmental pollution.
Fig. 3. Distribution diagram with extremely diminished wings
A lack of wings indicates that the body doesn’t want to show individual reactions/participate and that it is keeping its integrity with all of its forces. This is a sign of an over-compensated state (called masking in allergy studies), when neural and informational systems are no longer responding because the organism does not want to risk its stability (integrity). This is found mostly in patients with a severe chronic overload coupled with strong determination, like many high position bank managers, and noticeable emotional control (stoic patients), and also in some introverted, psychologically unstable patients. Patients with this type of distribution need certain preparatory treatments before becoming electrically responsive. This is possible with the treatment unit, or by applying longer “transmit” triggers of this diagnostic unit.
4. Result list
When the SUBSTANCE LIST window (located at the lower left corner of the screen, Fig. 4) appears after the calculations are finished, it begins by listing ALL SUBSTANCES. The x-coordinate of any substance (in the 240-point scale defined above) is listed starting with 120 (extreme right position in the distribution diagram) down to - 120 (extreme left position). If you want to examine the results within a specific category of substances, you can click on a group name and open that group. The substances which compose the group will appear (in “Normal Sort” mode) listed by their x-coordinate in descending order. One should keep in mind that all values are measured on a relative scale, all values are relative to the patient in the moment that the measurements were taken. This serves the purpose of obtaining the dynamics of the patient’s reactions to the tested substances during the REPEAT TEST period. However, a good starting point is to assume that values above 60 or below -60 indicate a “high reaction”. Always relate those values to the shape of the “Distribution Diagram”. Now we can compare the differences between the preliminary hypothesis and those values measured by the functional electro-diagnostic testing (FEDT) in the automatic mode.
There will always be only a partial overlap between the lists of the substances with expected high values and actually measured high absolute values. Those which confirm the preliminary diagnostic hypothesis need not be “Repeat tested”. Yet, if you want to estimate the pathogenic priority of these substances and test the organism’s specific regulative capacity toward each of them, the ADAPTATION TEST can be carried out. For substances which were expected but do not appear with high absolute numbers, the “Repeat Test” will help to decide whether we had a false assumption in the preliminary diagnostic hypothesis or may indicate that the organism needs more time to express itself specific to the investigated substance. This group of substances should be included in the REPEAT TEST phase of the diagnostic process. Some substances which were not explicitly expected, but came up with high absolute values correlate well to the pathogenesis and the epicrisis and will not necessitate further testing. For further investigations, this can be considered as similar to the substances belonging to Case “A”. Still more substances which were not explicitly expected but came up with a high absolute value will correlate either questionably or poorly. These substances need to be investigated more thoroughly should be added to the REPEAT TEST phase. It can happen that the user may not be familiar with some of the substances listed on the screen. In this case, the best thing to do for the moment is to ignore them. So as not to create confusion, make your search for the unknown substance after the well known substances have found their place in your diagnostic picture.
Fig. 4. End test result window.
5. Adaptation Test
The ADAPTATION TEST function consists of first, a period of contact for several seconds (adjustable from the software, usually 5 seconds) between the substance and the patient, then the usual testing of the patient’s reactions. This allows the “Adaptation Test Diagram” to provide an exact insight into the dynamics of the reaction. By repeating the ADAPTATION TEST, we can get the most detailed diagnostic information. “Reactivity” indicates the average of the 16 channels’ results during the entire period which was monitored. “Rise” indicates the highest deviation upwards from the average. “Fall” indicates the largest deviation downwards from the average. In the “Adaptation Test Diagram” on the vertical axis, we can see the amplitude of the signal measured in the same units as the x-axis of the STATISTICS TEST. On the horizontal axis, time is indicated in milliseconds. The actual measured values are depicted in red, “Reactivity” is represented by the flat green line corresponding to the overall average during the actual measurement period. (In later models, the vertical amplitude axis is represents only the actual interval according to the actually measured intensities during the “Test Measure Time” .) Normally, we expect “Reactivity” to settle down around 2048, “Rise” and “Fall” should be lower than 40 (in later models, 204.8, and 4.0 respectively). In order to understand the dynamics of the ADAPTATION TEST, the following tendencies are listed:
First of all, we follow the changes in the “Rise” and “Fall” parameters. The dynamics of the patient’s adaptation to the field of a therapeutically diluted substance is very significantly characterized by the fluctuations of its electric parameters in both frequency and amplitude. The maximum amplitude of fluctuation is characterized by the “Rise” and “Fall” values.
Usually, we include in the ADAPTATION TEST only substances which seem to play a key role in the epicrisis presented by the patient and here we want to collect information about which aspect of the pathology should be first treated. We are looking for not only the primary causes but also the principle stressors, the elimination of which brings about the opportunity for normal self-regulation of the organism. The ADAPTATION TEST makes it possible (through the reaction to the test substances) to identify the conditions under which the body’s self-regulation activities seem to be insufficient and substitution therapy or other more invasive treatments may be required.
In the case of a fast normalization of the “Rise”, “Fall”, and “Reactivity” values (e.g. within two ADAPTATION TESTS), we can conclude that a cell communication enhancement treatment (such as bioresonance therapy) would give the necessary first push and the organism could accomplish the rest of the recovery.
If the “Rise” and “Fall” values are only partially normalized (e.g., a stepwise function coming down from a higher value to a significantly lower value) we should consider a temporal administration of home medication in addition to cell communication adjustment treatments.
If “Rise” and “Fall” values don’t tend to normalize even after 3-4 ADAPTATION TESTS, then the organism is incapable of any detectable degree of self-correction concerning the tested substances. In this case, the revealed principle pathogen agent cannot be treated by a local enhancement of the damaged endogenous control mechanisms. Thus, the identified substance is a significant contributor to the patient’s pathology, and a longer preparation phase in the treatment is required before causal therapy can be applied (since at the moment, the organism has no vital reserves to react to a specific treatment regarding this substance).
In some few cases, we find a strange kind of extreme fluctuation of the “Rise” and “Fall” values (from several hundred to almost zero and back repeated several times). This indicates a very severe situation, potentially due to a lack of vital reserves. The body is trying to decide whether to ignore this substance or adapt to its field, and confusion ensues. This situation must be treated very carefully, and it requires that the body’s vital reserves are built up first because if the body is treated with this substance, the patient will develop a fever. Therefore, ignore this substance in the treatment until the patient’s vital reserves will be sufficient.
Fig 5. Adaptation Test result window.
Figure 6
As Fig.7 shows, all measurement characteristics can be adjusted from the software. We usually connect the patient and the test-substance for 40 ms and start measurement with the smallest possible delay time of 1 ms. One measurement block consists of 110 ms. With the usual measurement time of 80 ms this provides a 70 ms relaxation time for the body after connection with each subsequent test substance. Since immediate adaptational activity is the object of interest, these parameters are convenient in clinical practice. However, in the case of an extreme mesenchimal block (a solid disturbance in the mesenchimal matrix which makes endogenous information transfer, i.e., electric connection, very poor), the measurement and relaxation times should be elongated.
For carrying out the adaptation test, a longer period of connection between the test-substance and the patient (the Transmit time) is applied, usually 5-7 seconds. Changes in the dynamics of the reactivity are monitored (see references 60 and 61 for a more detailed description).
Figure 7:
